Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Brenus Pharma
Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide. We developped a…
Brenus Pharma
Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide. We developped a…
TL;DR
Stage: Clinical-stage biotech
Therapeutic focus: Allogeneic off-the-shelf immunotherapies for solid tumors
Lead candidate: STC-1010 for metastatic colorectal cancer
Recent financing: $25M Series A (Sep 2024, reported)
Headquarters: Clermont-Ferrand and Lyon, France
Company Overview
Problem Domain
Preventing cancer recurrence in solid tumors, with initial focus on colorectal cancer.
Industry
Biotechnology
Funding Track Record
$25M (reported)
Round reported with participation from UI Investissement, Meusinvest (Noshaq), Investsud, Crédit Agricole Centre-Est, Stéphane Legastelois and founder Jacques Gardette
Investor Signal
“Presence of institutional lead (Angelor) and regional/public investors; company reports ~€30M invested since 2020 and receipt of public grants”
